Advanced Cell-Free Autologous Exosome Signaling
BioExogen is a next-generation, cell-free biologic platform comprised of autologous exosome-rich signaling vesicles. These nanoparticles act as natural couriers for vital growth factors, cytokines, and regulatory proteins. It supports tissue repair, modulates inflammatory responses, and maintains cellular equilibrium through a refined, controlled biological signaling approach beyond traditional cell-based therapies.
Mechanism of Action:
It uses precise exosome-mediated signaling to orchestrate tissue repair and modulate inflammatory responses. These tiny particles can penetrate deeply into tissues to “reprogram” cells, guiding the body toward optimal regeneration and systemic balance.
Strategic Advantages:
BioExogen combines autologous exosomes with GFC to deliver a potent blend of growth factors, including PDGF, VEGF, EGF, IGF-1, and TGF-β. These bioactive components work together to enhance cellular signaling, support stem-cell communication, and encourage natural regenerative processes. The formulation is purified through a 0.22μm sterile membrane to maintain high potency and sterility. BioExogen also supports angiogenesis, activates fibroblasts essential for tissue repair, and helps create an optimized microenvironment that promotes cell survival, proliferation, and differentiation.
Advanced Protocol:
Step 1 : Blood Collection
A small amount of venous blood is collected into BioExogen tubes and gently mixed to maintain sample integrity.
Step 2: Platelet Activation
The tubes are left undisturbed to allow optimal platelet activation and the release of growth factors and exosomes.
Step 3: Growth Factor Separation
Centrifugation separates the plasma layer enriched with growth factors and regenerative components.
Step 4: Secondary Centrifugation
A two-stage centrifugation further refines and concentrates the exosome- and growth factor-rich plasma.
Step 5: Supernatant Collection
The purified supernatant is carefully extracted to obtain a clean exosome-rich solution.
Step 6: Filtration
The final plasma is filtered through a sterile membrane to ensure purity, sterility, and clinical-grade quality.
Final Product: BioExogen is now ready for direct clinical application or injection, representing a patent, patient-specific regenerative solution.